Adverse Events, Comorbidities, and HIV
The Latest

This Week in HIV Research: Resistance (Testing) Is Futile
Dec. 5, 2019: The value of pre-treatment drug resistance testing; resistance rates among viremic Americans; persistent pneumonia incidence among people with HIV; mixed HIV prevention results for the U.S. National HIV Strategy.

Montreal Researchers Explore Cannabis Use Among People With HIV and Hepatitis C
Montreal scientists found that 88% of cannabis users had an undetectable viral load. This suggests that a very large majority of cannabis users did not have problems adhering to antiretroviral therapy.

Top 10 HIV Clinical Developments of 2019
Will a given development in HIV make a difference in the clinic? Will it change practice? Is this something I should know if I take care of people living with HIV? The answer to each of these must be yes for the story to make the list.

Weight Gain and HIV Antiretrovirals: Lipodystrophy for the Integrase Era
In a busy year buzzing with the flight of potentially revolutionary new HIV medications, evidence of large weight increases accompanying dolutegravir and bictegravir has been a bombshell.

Tsepamo Study Provides Critical Update on Neural Tube Defects and Dolutegravir
A lot of pregnancies in Botswana were anxiously followed after results from the Tsepamo study were revealed in late 2018. Updated data provide a medium-sized sigh of relief.

Doxycycline for Bacterial STI Prevention: A Different Type of PrEP
An international team of experts conducted a thoughtful review of existing research regarding the use of doxycycline for STI prevention. Do the risks of its use outweigh the benefits?

This Week in HIV Research: How Many Pills Can a Person Miss?
Nov. 20, 2019: Adherence required to maintain suppression; the accuracy of Framingham scores in assessing cardiovascular risk; long-term success rates for kidney transplants; integration of hypertension services with HIV care.

Patients With HIV Should Think About How Many Pills They Take a Day
Taking more than five medications could be a problem. And many people with HIV are at risk of being on medication overload.

When It Comes to HIV and Fatigue, Nurses Have a Role in Breaking the Cycle
While there is not yet an app for helping patients to manage their fatigue, nurses can help patients get out of the house by finding a physical activity they enjoy.

Addressing Trauma Is an Essential Component of Hospital Care for People With HIV
Trauma-informed care should be implemented in all care settings, a study presented at the Association of Nurses in AIDS Care conference finds.